Campbell & CO Investment Adviser LLC Purchases New Holdings in Oscar Health, Inc. $OSCR

Campbell & CO Investment Adviser LLC acquired a new position in shares of Oscar Health, Inc. (NYSE:OSCR) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 30,892 shares of the company’s stock, valued at approximately $662,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of Oscar Health by 3.7% in the first quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company’s stock worth $258,247,000 after buying an additional 700,469 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in Oscar Health by 4.1% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company’s stock worth $155,043,000 after acquiring an additional 467,301 shares in the last quarter. Thrive Capital Management LLC increased its position in shares of Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. BIT Capital GmbH raised its stake in shares of Oscar Health by 1.1% in the 1st quarter. BIT Capital GmbH now owns 4,521,445 shares of the company’s stock valued at $59,276,000 after purchasing an additional 47,592 shares in the last quarter. Finally, Glynn Capital Management LLC lifted its position in shares of Oscar Health by 14.0% during the first quarter. Glynn Capital Management LLC now owns 3,115,217 shares of the company’s stock worth $40,840,000 after purchasing an additional 381,980 shares during the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Stock Performance

Shares of OSCR opened at $13.86 on Friday. The firm has a fifty day moving average of $18.84 and a 200-day moving average of $16.86. The company has a market cap of $3.67 billion, a price-to-earnings ratio of -12.37 and a beta of 1.88. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.92 and a current ratio of 0.92. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.80.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.02. The firm had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. Oscar Health’s quarterly revenue was up 23.2% compared to the same quarter last year. During the same period last year, the firm posted ($0.22) EPS. Oscar Health has set its FY 2025 guidance at EPS. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Piper Sandler lowered their price objective on Oscar Health from $14.00 to $13.00 and set a “neutral” rating for the company in a report on Thursday, August 14th. Wells Fargo & Company lowered their price target on Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a report on Thursday. Barclays raised their price objective on Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a research note on Monday, November 10th. Wall Street Zen lowered shares of Oscar Health from a “hold” rating to a “sell” rating in a research note on Saturday, August 9th. Finally, Baird R W downgraded shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 25th. Six research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, Oscar Health currently has an average rating of “Reduce” and a consensus target price of $13.14.

Insider Buying and Selling at Oscar Health

In other news, insider Mario Schlosser sold 395,000 shares of the business’s stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the completion of the transaction, the insider directly owned 501,148 shares in the company, valued at approximately $9,236,157.64. The trade was a 44.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 24.39% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.